
Investing.com··Nathan ReiffDexCom Surges on Strong Earnings, Analyst Confidence as CGM Market Expands
DexCom beats Q1 earnings with $1.2B revenue, boasts 20 Buy ratings. New products and margin expansion drive 40% upside potential.
MDTDXCMmanufacturing expansionanalyst-ratings









